Incuvate Sues Penumbra Over Alleged Patent Infringement of Thrombectomy Technology
Incuvate alleges that Penumbra’s THUNDERBOLT system infringes five of its patents covering blood-clot detection technology.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
Incuvate alleges that Penumbra’s THUNDERBOLT system infringes five of its patents covering blood-clot detection technology.
Lilly is calling on regulators, customs agencies, law enforcement authorities, online platforms, and payment companies to shut down the illegal retatrutide black market.
Novo Nordisk alleges Lilly’s advertisements for Zepbound and Mounjaro mislead consumers by comparing the drugs with lower-dose versions of Wegovy and Ozempic.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.


